2025. Car-T and Bispecific Antibodies for Refractory Non-Hodgkin Lymphoma: Long-Term Safety and Autoimmune Sequelae. Journal of Carcinogenesis. 24, 6s (Sep. 2025), 805–820. DOI:https://doi.org/10.64149/J.Carcinog.24.6s.805-820.